Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer

Nature(2007)10.1038/nature05945Source: DataRank Database

Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer is a research paper published in Nature (2007). On theSindex it has a DataRank of 1.3. It has been cited 5,398 times.

N/A

1.3DataRank · unranked

Scored on demand from live citation data

5,398 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:OA: closedTopics (20)Linked Datasets (25)DataCite Reuse (25)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (0/2)

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

1.3

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (19)

Young Lim Choi,Munehiro Enomoto,Shuji Takada ORCID,Yoshihiro Yamashita,Shunpei Ishikawa

Live enrichment

PubMed:17625570

closedLicense: http://www.springer.com/tdm

publisherhttp://www.nature.com/articles/nature05945.pdf

publisherhttp://www.nature.com/articles/nature05945

MeSH Terms

3T3 CellsChromosomes, Human, Pair 2AnimalsHumansMiceCarcinoma, Non-Small-Cell LungLung NeoplasmsCell Transformation, NeoplasticSerine EndopeptidasesReceptor Protein-Tyrosine KinasesCell Cycle ProteinsMicrotubule-Associated ProteinsOncogene Proteins, FusionCell ProliferationAmino Acid SequenceMutationMolecular Sequence DataProtein-Tyrosine KinasesChromosome InversionAnaplastic Lymphoma Kinase

Additional file 9 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis

10.6084/m9.figshare.12144525.v1figshare

Additional file 9 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis

10.6084/m9.figshare.12144525figshare

Additional file 8 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis

10.6084/m9.figshare.12144516.v1figshare

Additional file 8 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis

10.6084/m9.figshare.12144516figshare

Additional file 7 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis

10.6084/m9.figshare.12144510.v1figshare

Additional file 7 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis

10.6084/m9.figshare.12144510figshare

Additional file 6 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis

10.6084/m9.figshare.12144501.v1figshare

Additional file 6 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis

10.6084/m9.figshare.12144501figshare

Additional file 5 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis

10.6084/m9.figshare.12144498.v1figshare

Additional file 5 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis

10.6084/m9.figshare.12144498figshare

Additional file 4 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis

10.6084/m9.figshare.12144495.v1figshare

Additional file 4 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis

10.6084/m9.figshare.12144495figshare

Additional file 3 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis

10.6084/m9.figshare.12144489.v1figshare

Additional file 3 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis

10.6084/m9.figshare.12144489figshare

Additional file 2 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis

10.6084/m9.figshare.12144486.v1figshare

Additional file 2 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis

10.6084/m9.figshare.12144486figshare

Additional file 1 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis

10.6084/m9.figshare.12144483.v1figshare

Additional file 1 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis

10.6084/m9.figshare.12144483figshare

Additional file 11 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis

10.6084/m9.figshare.12144480.v1figshare

Additional file 11 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis

10.6084/m9.figshare.12144480figshare